Body Vision Medical Raises New Funding for Lung Imaging Expansion

August 06, 2026
Body Vision Medical has closed a new funding round led by Business Asia Consultants and Sprim Global Investments. The company said the capital will support global expansion of its AI imaging technology for early stage lung disease procedures.

Body Vision Medical has closed a new funding round led by Business Asia Consultants and Sprim Global Investments, the company said in a press release.

The company said the funding will support global expansion of its intraoperative imaging technology for procedures related to early stage lung disease. No funding amount was included in the announcement.

Body Vision Medical's LungVision platform provides AI based image guidance for minimally invasive procedures involving lung lesions. The company said the system is used to support early lung cancer diagnosis and localized treatment.

Sprim said Body Vision Medical has access to 46 countries through more than 20 distributors.

We hope you enjoyed this article.

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more